These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24839990)

  • 1. Potential of targeted drug delivery system for the treatment of bone metastasis.
    Vinay R; KusumDevi V
    Drug Deliv; 2016; 23(1):21-9. PubMed ID: 24839990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging therapeutic targets in breast cancer bone metastasis.
    Rose AA; Siegel PM
    Future Oncol; 2010 Jan; 6(1):55-74. PubMed ID: 20021209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications of bone metastases and the benefits of bone-targeted therapy.
    Lipton A
    Semin Oncol; 2010 Oct; 37 Suppl 2():S15-29. PubMed ID: 21111244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agents targeting prostate cancer bone metastasis.
    Mohammad KS; Fournier PG; Guise TA; Chirgwin JM
    Anticancer Agents Med Chem; 2009 Dec; 9(10):1079-88. PubMed ID: 19719455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RGD peptide conjugated liposomal drug delivery system for enhance therapeutic efficacy in treating bone metastasis from prostate cancer.
    Wang F; Chen L; Zhang R; Chen Z; Zhu L
    J Control Release; 2014 Dec; 196():222-33. PubMed ID: 25456829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering small-molecule and protein drugs for targeting bone tumors.
    Wang Y; Wang C; Xia M; Tian Z; Zhou J; Berger JM; Zhang XH; Xiao H
    Mol Ther; 2024 May; 32(5):1219-1237. PubMed ID: 38449313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone-Targeted Drug Delivery Systems and Strategies for Treatment of Bone Metastasis.
    Katsumi H; Yamashita S; Morishita M; Yamamoto A
    Chem Pharm Bull (Tokyo); 2020; 68(7):560-566. PubMed ID: 32611993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of calcium phosphate-binding liposome for drug delivery.
    Anada T; Takeda Y; Honda Y; Sakurai K; Suzuki O
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4148-50. PubMed ID: 19523821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted therapies in bone sarcomas: current approach and future directions.
    Yarber JL; Agulnik M
    Expert Opin Investig Drugs; 2011 Jul; 20(7):973-9. PubMed ID: 21510829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of Nanodrug Delivery Systems for Tumor Bone Metastasis.
    Zhai X; Peng S; Zhai C; Wang S; Xie M; Guo S; Bai J
    Curr Pharm Des; 2024; 30(15):1136-1148. PubMed ID: 38551047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in Bone-targeted Drug Delivery Systems for Neoadjuvant Chemotherapy for Osteosarcoma.
    Li CJ; Liu XZ; Zhang L; Chen LB; Shi X; Wu SJ; Zhao JN
    Orthop Surg; 2016 May; 8(2):105-10. PubMed ID: 27384718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different Targeting Strategies for Treating Breast Cancer Bone Metastases.
    Irshad I; Varamini P
    Curr Pharm Des; 2018; 24(28):3320-3331. PubMed ID: 29921200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Research progress of bone-targeted drug delivery system on metastatic bone tumors.
    Hu B; Zhang Y; Zhang G; Li Z; Jing Y; Yao J; Sun S
    J Control Release; 2022 Oct; 350():377-388. PubMed ID: 36007681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Target specific delivery of anticancer drug in silk fibroin based 3D distribution model of bone-breast cancer cells.
    Subia B; Dey T; Sharma S; Kundu SC
    ACS Appl Mater Interfaces; 2015 Feb; 7(4):2269-79. PubMed ID: 25557227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone targeted therapy in breast cancer: present and future.
    Huober J; Thürlimann B
    Crit Rev Oncol Hematol; 2010 Apr; 74 Suppl 1():S7-10. PubMed ID: 20427030
    [No Abstract]   [Full Text] [Related]  

  • 17. Evolution of treatment options for patients with CRPC and bone metastases: bone-targeted agents that go beyond palliation of symptoms to improve overall survival.
    Rove KO; Crawford ED
    Oncology (Williston Park); 2011 Dec; 25(14):1362-70, 1375-81, 1387. PubMed ID: 22329188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone scaffolds-based localized drugs delivery for osteosarcoma: current status and future perspective.
    Liang W; Long H; Zhang H; Bai J; Jiang B; Wang J; Fu L; Ming W; Zhao J; Zeng B
    Drug Deliv; 2024 Dec; 31(1):2391001. PubMed ID: 39239763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current trials using bone-targeting agents in prostate cancer.
    Tu SM; Lin SH
    Cancer J; 2008; 14(1):35-9. PubMed ID: 18303481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Bone Targeting Drugs.
    Stapleton M; Sawamoto K; Alméciga-Díaz CJ; Mackenzie WG; Mason RW; Orii T; Tomatsu S
    Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28644392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.